Frontlight ResearchEarly access
Trial site
Tampa General Medical Group
- 1running trial
- 4closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Phase
- Phase 22 trials
- Phase 31 trial
- Status
- Completed2 trials
- Terminated2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Intercept Pharmaceuticals3 trials
- Target PharmaSolutions, Inc.2 trials
Running trials
Closed trials
Terminated
Terminated
FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026